Moderna
MRNA
#1473
Rank
S$15.71 B
Marketcap
$40.73
Share price
-2.23%
Change (1 day)
-68.43%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -S$3.16 Billion

According to Moderna 's latest financial reports the company's current earnings are S$5.05 Billion. In 2023 the company made an earning of -S$5.26 Billion a decrease over its 2022 earnings that were of S$12.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$3.16 Billion-39.93%
2023 -S$5.26 Billion-140.65%
2022 S$12.92 B-27.81%
2021 S$17.89 B-1911.15%
2020 -S$0.99 Billion44.7%
2019 -S$0.69 Billion28.63%
2018 -S$0.54 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$55.67 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
S$20.14 B-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$56.19 Million-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.32 Billion-89.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$18.35 B-685.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-S$0.81 Billion-74.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$23.46 B-848.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA